Vioxx Schmiox: Merck’s Still Outperforming the Competition, Says John Fisher

Fisher had high praise for Merck's CEO and says that, overall, the pharma industry's pipeline is improving.  Tune in to Tuesday's interview on Bloomberg, taped the day that Januvia, Merck's Type 2 Diabetes treatment, was approved by FDA.

Pharma Pipeline Strengthening: Financial Analyst John Fisher

BLOOM (BLOOM), National

Tue 17 Oct 2006 01:50 PM EDT

Portfolio manager John Fisher weighs in on Big Pharma, with high praise for Merck, whose new Type 2 Diabetes therapy was approved by FDA yesterday